Clinical Trial

A Study of Neuropathy Caused by Enfortumab Vedotin in People With Urothelial Carcinoma

Name: A Study of Neuropathy Caused by Enfortumab Vedotin in People With Urothelial Carcinoma — clinical trial record (NCT07390617)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

The purpose of this study is to see how results of nerve tests change in people with urothelial cancer who receive treatment with enfortumab vedotin (EV)

Protocol Amendment History 1 change

critical Primary endpoint(s) modified 2026-05-30

Trial Details

NCT Number	NCT07390617
Lead Sponsor	Memorial Sloan Kettering Cancer Center
Conditions	Neuropathy, Urothelial Carcinoma, Metastatic Urothelial Carcinoma
Enrollment	50 participants
Start Date	2026-01-20
Primary Completion	2028-01-20 (estimated)
Study Completion	2028-01-20 (estimated)
Updated on ClinicalTrials.gov	2026-05-29